Ackman Wields Finance Tool With Morbid Past for New Venture (Bloomberg) Bill Ackman is putting a modern-day spin on a centuries-old financial innovation...
Keep Reading →
July 8 - Hedge Funds, Insider Trading - Comments
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares...
Keep Reading →
May 8 - Insider Trading, News, Tech - Comments
1. U.S. Stock Market: “Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty...
Keep Reading →
May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. US Stock Market: “U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while...
Keep Reading →
April 17 - Commodities, Gold, Market Movers, News, Tech - Comments
Traders are watching Incyte Corporation (NASDAQ:INCY) after Geoff Meacham of Barclays hiked his price target on the biotech to $185 per share from $...
Keep Reading →
April 7 - News - Comments
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly...
Keep Reading →
April 4 - Lists, News - Comments
Which are the most successful innovative companies in the world in 2016? Bringing something new to the table is something that seems to be difficult these...
Keep Reading →
October 26 - Hedge Funds, Lists, News - Comments
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused...
Keep Reading →
May 7 - Hedge Fund Analysis, Hedge Funds, News - Comments
It is generally believed that individuals seeking to become millionaires (and who isn’t?) need to think and act like millionaires. That’s probably...
Keep Reading →
March 18 - Hedge Funds, News - Comments
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies...
Keep Reading →
February 25 - Hedge Funds, News - Comments
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker...
Keep Reading →
December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
As the markets are mixed on Tuesday, fueled by a surge in oil prices, among the crowd of stocks moving in different directions, shares of Encana Corporation...
Keep Reading →
October 6 - Market Movers, News - Comments
Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions...
Keep Reading →
September 29 - Market Movers, News - Comments
Was Baker Bros. Advisors‘ investment in XOMA Corp (NASDAQ:XOMA) a mistake? According to a recent filing with the Securities and Exchange Commission...
Keep Reading →
July 26 - Hedge Funds, News - Comments
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting...
Keep Reading →
July 10 - Hedge Funds, News - Comments
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc...
Keep Reading →
March 5 - Hedge Funds, News - Comments
Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares...
Keep Reading →
January 2 - Hedge Funds, News - Comments
Julian and Felix Baker and their hedge fund, Baker Bros. Advisors, reported slicing their exposure at Incyte Corporation (NASDAQ:INCY) to 19.53 million...
Keep Reading →
November 15 - Hedge Funds, News - Comments
Is Theravance Inc (NASDAQ:THRX) a good investment? At the moment, there are many indicators investors can use to analyze stocks. Some of the most under...
Keep Reading →
September 12 - News - Comments
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment...
Keep Reading →
September 10 - News - Comments
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use...
Keep Reading →
August 30 - News - Comments
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in...
Keep Reading →
August 28 - News - Comments
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading...
Keep Reading →
August 27 - News - Comments
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge...
Keep Reading →
August 27 - News - Comments
Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets....
Keep Reading →
August 25 - News - Comments
Editor’s Note: Incyte Corporation (NASDAQ:INCY), Diamond Foods, Inc. (NASDAQ:DMND), Organovo Holdings Inc (NYSEMKT:ONVO) Incyte Rises Most in...
Keep Reading →
August 21 - News - Comments
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is really beginning to heat up, and it’s offering investors...
Keep Reading →
August 16 - News - Comments
Seattle Genetics, Inc. (NASDAQ:SGEN) was in 8 hedge funds’ portfolio at the end of the first quarter of 2013. SGEN has experienced a decrease in...
Keep Reading →
June 13 - News - Comments
Is Incyte Corporation (NASDAQ:INCY) a buy, sell, or hold? Investors who are in the know are taking an optimistic view. The number of bullish hedge fund...
Keep Reading →
June 3 - News - Comments
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds’ portfolio at the end of December. INFI has experienced an increase in enthusiasm...
Keep Reading →
May 9 - News - Comments
Theravance Inc (NASDAQ:THRX) has experienced a decrease in support from the world’s most elite money managers of late, but insiders on the whole...
Keep Reading →
April 15 - News - Comments
A quick way to discover potentially undervalued stocks is to look for ones with a current price below the current mean analyst target price. Last year...
Keep Reading →
November 16 - Stock Analysis - Comments
